Jennifer Bienaime with Jean-Jacques Bienaime
Jean-Jacques Bienaime Archives - Business & Finance | Business & Finance
jean-jacques-bienaime-biomarin-ceo | North Bay Life Science Alliance
Chairman and CEO of BioMarin, Jean-Jacques Bienaime is photographed... News Photo - Getty Images
Jean-Jacques Bienaime with Jennifer Kano
BioMarin Pharmaceutical 1Q loss rises amid higher expenses for product launch
Jean Jacques Bienaime – North Bay Leadership Council
BioMarin Pharmaceutical (NASDAQ: BMRN) wins FDA approval for $700,000 Batten disease drug Brineura - San Francisco Business Times
Jean-Jacques Bienaime - Crunchbase Person Profile
Bay Area Biotech 2015: The I-List — Tracking the most innovative biotechnology in the Bay Area - San Francisco Business Times
Jan-Jacques Bienaime with Lana Bondar
Jean-Jacques Bienaimé | Health Evolution
3.5: Testimony from Jean-Jacques Bienaimé (CEO - BioMarin Pharmaceutical) - Unit 3: Investing in Europe | Coursera
Jean Jacques Bienaime Sells 1,500 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock - Opera News
BioMarin Pharmaceutical Inc - Jean-Jacques Bienaimé Chairman and Chief Executive Officer
Jean-Jacques Bienaimé BioMarin | The CEO Magazine
BioMarin Pharmaceutical shares rise after possible takeover from Roche
Jean-Jacques Bienaimé (76) – 1st Alumnus with the title of ESCP Doctor Honoris Causa – ESCP
Jean-Jacques Bienaimé - Chairman & CEO at BioMarin Pharmaceutical | The Org
Jean-Jacques Bienaimé (76) – 1st Alumnus with the title of ESCP Doctor Honoris Causa – ESCP
BioMarin CEO Jean-Jacques Bienaimé - Xconomy
BioMarin (NASDAQ: BMRN) sues to stop Dr. Reddy's (NYSE: RDY) from selling generic version of PKU drug Kuvan - San Francisco Business Times
J.P. Morgan Healthcare Conference
Jean-Jacques Bienaimé - Advisor at Longwood Fund | The Org
Jean-Jacques Bienaime
People | Nature Biotechnology
